Tonact (Atorvastatin Calcium 10 mg)
Brand name:
Tonact
Generic name:
Atorvastatin Calcium
Actual product may differ in appearance from image shown.
Tonact is a cholesterol lowering medication that contains atorvastatin calcium, a widely used statin designed to help reduce LDL bad cholesterol and support healthier lipid balance.
By limiting cholesterol production in the liver, this treatment can also help lower triglycerides and modestly raise HDL good cholesterol, which may reduce long term cardiovascular risk when combined with lifestyle changes.
Tonact is commonly chosen for people who need dependable daily control for conditions such as hypercholesterolemia, mixed dyslipidemia, or prevention of heart related events in higher risk patients. For best results, use it consistently, follow a heart smart diet, and keep regular lab monitoring for lipid levels and liver enzymes.
Like other statins, it may interact with certain medicines and is not suitable for everyone, so review medical history before use. This product page provides clear guidance for safe dosing, expected benefits, and practical precautions.
Manufacturer:
Active ingredients:
Tonact is a daily statin therapy containing atorvastatin calcium that helps reduce LDL bad cholesterol, support healthier lipid balance, and lower long term cardiovascular risk when combined with diet and exercise, making it a practical option for hypercholesterolemia and mixed dyslipidemia management with consistent monitoring; chemical formula: C₆₆H₆₈CaF₂N₄O₁₀.
Indications:
- High LDL cholesterol (Hypercholesterolemia): Tonact is used to lower elevated LDL levels by reducing cholesterol production in the liver, helping decrease long term cardiovascular risk;
- Mixed dyslipidemia: It can improve an unhealthy lipid profile where LDL is high and triglycerides are elevated, while also supporting a modest increase in HDL in some patients;
- Hypertriglyceridemia: Tonact may be prescribed to lower high triglycerides, especially when lifestyle changes alone are not enough and overall cardiovascular risk is increased;
- Familial hypercholesterolemia (Inherited high cholesterol): It is used for genetic cholesterol disorders where LDL is very high and requires consistent long term statin therapy;
- Primary prevention of cardiovascular disease in high risk patients: It may be used to reduce the risk of heart attack or stroke in people with multiple risk factors such as hypertension, diabetes, smoking history, obesity, or strong family history;
- Secondary prevention after cardiovascular events: Tonact is commonly prescribed after a heart attack, stroke, or established atherosclerotic disease to reduce the chance of future events;
- Atherosclerotic cardiovascular disease (ASCVD): It is indicated for patients with confirmed plaque related disease such as coronary artery disease or peripheral arterial disease to reduce LDL aggressively and stabilize plaques;
- Diabetes with elevated cardiovascular risk: Many patients with diabetes are prescribed atorvastatin to reduce cardiovascular risk even when cholesterol is not extremely high, depending on age and risk profile;
- Metabolic syndrome with abnormal lipids: It may be used when abdominal obesity, insulin resistance, and lipid abnormalities create higher long term cardiovascular risk;
- Elevated non-HDL cholesterol or ApoB driven risk: Tonact may be chosen when the goal is to reduce total atherogenic particles beyond LDL alone, based on lab markers and clinician targets.
- Mixed dyslipidemia: It can improve an unhealthy lipid profile where LDL is high and triglycerides are elevated, while also supporting a modest increase in HDL in some patients;
- Hypertriglyceridemia: Tonact may be prescribed to lower high triglycerides, especially when lifestyle changes alone are not enough and overall cardiovascular risk is increased;
- Familial hypercholesterolemia (Inherited high cholesterol): It is used for genetic cholesterol disorders where LDL is very high and requires consistent long term statin therapy;
- Primary prevention of cardiovascular disease in high risk patients: It may be used to reduce the risk of heart attack or stroke in people with multiple risk factors such as hypertension, diabetes, smoking history, obesity, or strong family history;
- Secondary prevention after cardiovascular events: Tonact is commonly prescribed after a heart attack, stroke, or established atherosclerotic disease to reduce the chance of future events;
- Atherosclerotic cardiovascular disease (ASCVD): It is indicated for patients with confirmed plaque related disease such as coronary artery disease or peripheral arterial disease to reduce LDL aggressively and stabilize plaques;
- Diabetes with elevated cardiovascular risk: Many patients with diabetes are prescribed atorvastatin to reduce cardiovascular risk even when cholesterol is not extremely high, depending on age and risk profile;
- Metabolic syndrome with abnormal lipids: It may be used when abdominal obesity, insulin resistance, and lipid abnormalities create higher long term cardiovascular risk;
- Elevated non-HDL cholesterol or ApoB driven risk: Tonact may be chosen when the goal is to reduce total atherogenic particles beyond LDL alone, based on lab markers and clinician targets.